The goal of the present work was to characterize a hydrogel material for localized spinal cord delivery. To address spinal cord injuries, an injectable in situ gelling system was tested utilizing a simple, effective, and rapid cross-linking method via Michael addition. Thiolated chitosan material and maleimide-terminated polyethylene glycol material were mixed to form a hydrogel and evaluated in vitro and in vivo. Three distinct thiolated chitosan precursors were made by varying reaction conditions; a modification of chitosan with Traut’s reagent (2-iminothiolane) displayed the most attractive hydrogel properties once mixed with polyethylene glycol. The final hydrogel chosen for animal testing had a swelling ratio (Q) of 57.5 ± 3.4 and elastic modulus of 378 ± 72 Pa. After confirming low cellular toxicity in vitro, the hydrogel was injected into the spinal cord of rats for 1 and 2 weeks to assess host reaction. The rats displayed no overt functional deficits due to injection following initial surgical recovery and throughout the 2-week period after for both the saline-injected sham group and hydrogel-injected group. The saline and hydrogel-injected animals both showed a similar response from ED1+ microglia and GFAP overexpression. No significant differences were found between saline-injected and hydrogel-injected groups for any of the measures studied, but there was a trend toward decreased affected area size from 1 to 2 weeks in both groups. Access to the central nervous system is limited by the blood–brain barrier for noninvasive therapies; further development of the current system for localized drug or cellular delivery has the potential to shape treatments of spinal cord injury.
LiHKoenigAMSloanPet al.
In vivo assessment of guided neural stem cell differentiation in growth factor immobilized chitosan-based hydrogel scaffolds. Biomaterials2014;
35: 9049–9057.
12.
LiHHamTRNeillNet al.
A hydrogel bridge incorporating immobilized growth factors and neural stem/progenitor cells to treat spinal cord injury. Adv Healthcare Mater2016;
5: 802–812.
13.
FuhrmannTObermeyerJTatorCHet al.
Click-crosslinked injectable hyaluronic acid hydrogel is safe and biocompatible in the intrathecal space for ultimate use in regenerative strategies of the injured spinal cord. Methods2015;
84: 60–69.
14.
ParkJLimEBackSet al.
Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. J Biomed Mater Res2010;
93A: 1091–1099.
15.
StabenfeldtSELaPlacaMC.Variations in rigidity and ligand density influence neuronal response in methylcellulose-laminin hydrogels. Acta Biomater2011;
7: 4102–4108.
16.
TateMCShearDAHoffmanSWet al.
Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials2001;
22: 1113–1123.
17.
AustinJWKangCEBaumannMDet al.
The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditis. Biomaterials2012;
33: 4555–4564.
18.
Elliott DonaghueITatorCHShoichetMS.Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord. Biomater Sci2015;
3: 65–72.
19.
BaumannMDKangCEStanwickJCet al.
An injectable drug delivery platform for sustained combination therapy. J Control Release2009;
138: 205–213.
20.
BaumannMDKangCETatorCHet al.
Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury. Biomaterials2010;
31: 7631–7639.
21.
YaoZAChenFJCuiHLet al.
Efficacy of chitosan and sodium alginate scaffolds for repair of spinal cord injury in rats. Neural Regen Res2018;
13: 502–509.
22.
ChedlyJSoaresSMontembaultAet al.
Physical chitosan microhydrogels as scaffolds for spinal cord injury restoration and axon regeneration. Biomaterials2017;
138: 91–107.
23.
NawrotekKMarquesteTModrzejewskaZet al.
Thermogelling chitosan lactate hydrogel improves functional recovery after a C2 spinal cord hemisection in rat. J Biomed Mater Res2017;
105: 2004–2019.
RaoJSZhaoCZhangAFet al.
NT3-chitosan enables de novo regeneration and functional recovery in monkeys after spinal cord injury. Proc Natl Acad Sci USA2018;
115: E5595–E5604.
26.
AmrSMGoudaAKoptanWTet al.
Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of 14 patients. J Spinal Cord Med2014;
37: 54–71.
27.
HornofMDKastCEBernkopSA.In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Eur J Pharm Biopharm2003;
55: 185–190.
28.
KastCEBernkopSA.Thiolated polymers – thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials2001;
22: 2345–2352.
29.
BernkopSAHornofMZoidlT.Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm2003;
260: 229–237.
30.
KastCFrickWLosertUet al.
Chitosan-thioglycolic acid conjugate: a new scaffold material for tissue engineering?Int J Pharm2003;
256: 183–189.
31.
NairDPodgorskiMChataniSet al.
The thiol-Michael addition click reaction: a powerful and widely used tool in materials chemistry. Chem Mater2014;
26: 724–744.
32.
PhelpsEAEnemchukwuNOFioreVFet al.
Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery. Adv Mater2012;
24: 64–70.
33.
DarlingNHungYSharmaSet al.
Controlling the kinetics of thiol-maleimide Michael-type addition gelation kinetics for the generation of homogenous poly(ethylene glycol) hydrogels. Biomaterials2016;
101: 199–206.
34.
YuLMYKazazianKShoichetMS.Peptide surface modification of methacrylamide chitosan for neural tissue engineering applications. J Biomed Mater Res2007;
82A: 243–255.
35.
TengDYWuZMZhangXGet al.
Synthesis and characterization of in situ cross-linked hydrogel based on self-assembly of thiol-modified chitosan with PEG diacrylate using Michael type addition. Polymer2010;
51: 639–646.
36.
WijekoonAFountas-DavisNLeipzigND.Fluorinated methacrylamide chitosan hydrogel systems as adaptable oxygen carriers for wound healing. Acta Biomater2013;
9: 5653–5664.
37.
VanderhooftJLMannBKPrestwichGD.Synthesis and characterization of novel thiol-reactive poly(ethylene glycol) cross-linkers for extracellular-matrix-mimetic biomaterials. Biomacromolecules2007;
8: 2883–2889.
38.
BaldwinADRobinsonKGMilitarJLet al.
In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release. J Biomed Mater Res2012;
100A: 2106–2118.
39.
ZhouYLZhaoJSunXLet al.
Rapid gelling chitosan/polylysine hydrogel with enhanced bulk cohesive and interfacial adhesive force: mimicking features of epineurial matrix for peripheral nerve anastomosis. Biomacromolecules2016;
17: 622–630.
40.
LiHWijekoonALeipzigND.3D differentiation of neural stem cells in macroporous photopolymerizable hydrogel scaffolds. PLoS One2012;
7.
41.
LeeFChungJEKurisawaM.An injectable hyaluronic acid-tyramine hydrogel system for protein delivery. J Control Release2009;
134: 186–193.
42.
FanMMaYMaoJHet al.
Cytocompatible in situ forming chitosan/hyaluronan hydrogels via a metal-free click chemistry for soft tissue engineering. Acta Biomater2015;
20: 60–68.
43.
TruongVXAblettMPGilbertHTJet al.
In situ-forming robust chitosan-poly(ethylene glycol) hydrogels prepared by copper-free azide-alkyne click reaction for tissue engineering. Biomater Sci2014;
2: 167–175.
44.
ChengSClarkeEBilstonL.Rheological properties of the tissues of the central nervous system: a review. Med Eng Phys2008;
30: 1318–1337.
45.
KoserDMoeendarbaryEHanneJet al.
CNS cell distribution and axon orientation determine local spinal cord mechanical properties. Biophys J2015;
108: 2137–2147.
46.
TaylorZMillerK.Reassessment of brain elasticity for analysis of biomechanisms of hydrocephalus. J Biomech2004;
37: 1263–1269.
MohrmanAEFarragMHuangHet al.
Spinal cord transcriptomic and metabolomic analysis after excitotoxic injection injury model of syringomyelia. J Neurotrauma2017;
34: 720–733.
49.
CheYJChenLLvGHet al.
In situ gel delivery system of methylprednisolone for post traumatic spinal injuries. J Biomater Tissue Eng2015;
5: 552–556.
50.
NomuraHZahirTKimHet al.
Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection. Tissue Eng Part A2008;
14: 649–665.
51.
HamannMCJTatorCHShoichetMS.Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord. Exp Neurol2005;
194: 106–119.
52.
ChvatalSAKimYTBratt-LealAMet al.
Spatial distribution and acute anti-inflammatory effects of methylprednisolone after sustained local delivery to the contused spinal cord. Biomaterials2008;
29: 1967–1975.
53.
NajafiEBilstonLESongXet al.
Longitudinal measurements of syrinx size in a rat model of posttraumatic syringomyelia. J Neurosurgery Spine2016;
24: 941–948.
54.
KangCEPoonPCTatorCHet al.
A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair. Tissue Eng Part A2009;
15: 595–604.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
